Latest Apicomplexa Stories
An international team of scientists has announced a breakthrough in the fight against malaria, paving the way for the development of new drugs to treat the deadly disease.
Researchers have discovered a group of chemical compounds that might one day be developed into drugs that can treat malaria infection in both the liver and the bloodstream.
A international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead to a new generation of antimalarial drugs capable of not only alleviating symptoms but also preventing the deadly disease.
The discovery of a new class of dual-acting antimalarial compounds - the imidazolopiperazines (IZPs) – was published in the journal Science online, at the Science Express website today1.
A study conducted by researchers at the Johns Hopkins Malaria Research Institute and their Zambian colleagues detected contrasting patterns of drug resistance in malaria-causing parasites taken from both humans and mosquitoes in rural Zambia.
Researchers have revealed a new discovery in understanding how a malaria parasite invades human red blood cells.
For some time now, artemisinin, derived from a Chinese herb, has been the most powerful treatment available against malaria.
A large study from Africa, published in this week's PLoS Medicine, has found that in a direct comparison, three types of new, fast-acting antimalarial artemisinin-based combination therapy drugs (ACTs), which comprise artemisinin derivatives in combination with a partner antimalarial drug, AL (artesunate–mefloquine), ASAQ (artesunate–amodiaquine) and DHAPQ (dihydroartemisinin–piperaquine) are all effective for treating children with uncomplicated malaria.
- Withering but not falling off, as a blossom that persists on a twig after flowering.
More Images (1 images) »